Cancer Vaccines, Treatment of the Future: With Emphasis on HER2-Positive Breast Cancer.

Pallerla, Sandeep; Abdul, Ata Ur Rahman Mohammed; Comeau, Jill; Jois, Seetharama

Pallerla, Sandeep; Abdul, Ata Ur Rahman Mohammed; Comeau, Jill; Jois, Seetharama.

Afiliação

Pallerla S; School of Pharmaceutical and Toxicological Sciences and School of Clinical Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA.
Abdul AURM; Independent Researcher, Wharton, NJ 07885, USA.
Comeau J; School of Pharmaceutical and Toxicological Sciences and School of Clinical Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA.
Jois S; School of Pharmaceutical and Toxicological Sciences and School of Clinical Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA.

Int J Mol Sci ; 22(2)2021 Jan 14.

Article em En | MEDLINE | ID: mdl-33466691

Assuntos

Neoplasias da Mama/prevenção & controle; Vacinas Anticâncer/uso terapêutico; Neoplasias/prevenção & controle; Receptor ErbB-2/análise; Animais; Neoplasias da Mama/patologia; Feminino; Humanos; Neoplasias/patologia; Microambiente Tumoral

Palavras-chave

DNA-based vaccine; HER2; breast cancer; cell-based vaccine; therapeutic vaccine; vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Vacinas Anticâncer / Neoplasias Limite: Animals / Female / Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google